Zacks Research Expects Reduced Earnings for Elevance Health

Elevance Health, Inc. (NYSE:ELV) – Analysts at Zacks Research decreased their Q2 2025 EPS estimates for shares of Elevance Health in a research note issued to investors on Thursday, January 30th. Zacks Research analyst K. Dey now anticipates that the company will post earnings per share of $9.85 for the quarter, down from their prior forecast of $10.35. The consensus estimate for Elevance Health’s current full-year earnings is $34.07 per share. Zacks Research also issued estimates for Elevance Health’s Q4 2025 earnings at $5.31 EPS, FY2025 earnings at $34.16 EPS, Q1 2026 earnings at $12.30 EPS, Q2 2026 earnings at $11.67 EPS, Q3 2026 earnings at $10.23 EPS, Q4 2026 earnings at $6.10 EPS and FY2026 earnings at $40.30 EPS.

Several other equities analysts also recently weighed in on the company. Raymond James set a $485.00 price target on Elevance Health in a report on Friday, October 18th. Stephens cut shares of Elevance Health from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $520.00 to $440.00 in a report on Wednesday, January 22nd. Royal Bank of Canada cut their price target on shares of Elevance Health from $585.00 to $478.00 and set an “outperform” rating on the stock in a report on Friday, October 18th. Truist Financial reduced their price target on shares of Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Morgan Stanley cut their target price on Elevance Health from $643.00 to $551.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Three investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $517.03.

Elevance Health Stock Down 0.7 %

Shares of NYSE:ELV opened at $402.29 on Monday. The company has a current ratio of 1.45, a quick ratio of 1.50 and a debt-to-equity ratio of 0.71. The stock has a fifty day simple moving average of $386.45 and a two-hundred day simple moving average of $456.00. Elevance Health has a 12-month low of $362.21 and a 12-month high of $567.26. The stock has a market capitalization of $93.30 billion, a price-to-earnings ratio of 15.71, a PEG ratio of 1.19 and a beta of 0.83.

Elevance Health (NYSE:ELV) last released its earnings results on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.80 by $0.04. Elevance Health had a net margin of 3.38% and a return on equity of 18.28%.

Institutional Trading of Elevance Health

Several large investors have recently added to or reduced their stakes in ELV. State Street Corp grew its position in shares of Elevance Health by 1.2% during the 3rd quarter. State Street Corp now owns 10,687,998 shares of the company’s stock valued at $5,557,759,000 after acquiring an additional 129,709 shares during the period. Geode Capital Management LLC lifted its position in Elevance Health by 1.8% during the third quarter. Geode Capital Management LLC now owns 4,848,020 shares of the company’s stock valued at $2,511,814,000 after purchasing an additional 85,770 shares in the last quarter. Sanders Capital LLC grew its holdings in Elevance Health by 1.0% during the third quarter. Sanders Capital LLC now owns 4,609,258 shares of the company’s stock valued at $2,396,814,000 after purchasing an additional 44,805 shares during the period. Wellington Management Group LLP increased its position in Elevance Health by 6.9% in the third quarter. Wellington Management Group LLP now owns 4,461,585 shares of the company’s stock worth $2,320,024,000 after buying an additional 286,905 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA raised its stake in shares of Elevance Health by 16.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,397,258 shares of the company’s stock worth $1,246,574,000 after buying an additional 334,552 shares during the period. 89.24% of the stock is currently owned by institutional investors.

Elevance Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Monday, March 10th will be paid a $1.71 dividend. This represents a $6.84 annualized dividend and a dividend yield of 1.70%. The ex-dividend date of this dividend is Monday, March 10th. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. Elevance Health’s dividend payout ratio is 25.46%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.